0 or 2 credits
Fall 2025 Lecture Upper Division
This course will be offered as a lecture course with some interactive discussion and problem solving applications. In addition, students will be required to complete several distance learning activities that relate to/enhance the materials that will be covered in the lecture period. This course is the final course in the NUPH series that can be used to count toward the 200 hours of didactic training required for Authorized Nuclear pharmacist (ANP) status.
Learning Outcomes1Understand the principles of drug design, radiopharmaceutical chemistry, product compounding and clinical applications as they apply to the currently available radiopharmaceutical products.
2Understand the differences between SPECT and PET radiopharmaceuticals.
3Understand the role of nuclear medicine procedures in the diagnostic and therapeutic workup of patients with certain clinical conditions.
Prerequisites
Restrictions
made by Purdue students.